In contrast to the well-documented role of CDKN1B and CCND2 in the pathogenesis of solid tumors, knowledge is still lacking about the polymorphisms in the CDKN1B and CCND2 genes in patients with CLL. The gene discussed is CCND2; the disease is B-cell chronic lymphocytic leukemia.